US 11478479
Dosing with an azolopyrimidine compound
granted A61KA61K31/506A61K31/555
Quick answer
US patent 11478479 (Dosing with an azolopyrimidine compound) held by Arcus Biosciences, Inc. expires Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Arcus Biosciences, Inc.
- Grant date
- Tue Oct 25 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Oct 20 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 25
- CPC classes
- A61K, A61K31/506, A61K31/555, A61K31/704, A61K33/243